141 related articles for article (PubMed ID: 26873435)
1. Increased Expression of Tripartite Motif (TRIM) 47 Is a Negative Prognostic Predictor in Human Prostate Cancer.
Fujimura T; Inoue S; Urano T; Takayama K; Yamada Y; Ikeda K; Obinata D; Ashikari D; Takahashi S; Homma Y
Clin Genitourin Cancer; 2016 Aug; 14(4):298-303. PubMed ID: 26873435
[TBL] [Abstract][Full Text] [Related]
2. TRIM47 is up-regulated in colorectal cancer, promoting ubiquitination and degradation of SMAD4.
Liang Q; Tang C; Tang M; Zhang Q; Gao Y; Ge Z
J Exp Clin Cancer Res; 2019 Apr; 38(1):159. PubMed ID: 30979374
[TBL] [Abstract][Full Text] [Related]
3. TRIM47 overexpression is a poor prognostic factor and contributes to carcinogenesis in non-small cell lung carcinoma.
Han Y; Tian H; Chen P; Lin Q
Oncotarget; 2017 Apr; 8(14):22730-22740. PubMed ID: 28186994
[TBL] [Abstract][Full Text] [Related]
4. Trim47 overexpression correlates with poor prognosis in gastric cancer.
Xia Y; Wei Z; Huang W; Wei X; He Y
Neoplasma; 2021 Mar; 68(2):307-316. PubMed ID: 33350849
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of TRIM47 inhibits breast cancer tumorigenesis and progression through the inactivation of PI3K/Akt pathway.
Wang Y; Liu C; Xie Z; Lu H
Chem Biol Interact; 2020 Feb; 317():108960. PubMed ID: 31981573
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of steroid and xenobiotic receptor and its targeted gene CYP3A4 in human prostate cancer.
Fujimura T; Takahashi S; Urano T; Tanaka T; Zhang W; Azuma K; Takayama K; Obinata D; Murata T; Horie-Inoue K; Kodama T; Ouchi Y; Homma Y; Inoue S
Cancer Sci; 2012 Feb; 103(2):176-80. PubMed ID: 22050110
[TBL] [Abstract][Full Text] [Related]
7. Upregulated Tripartite Motif 47 Could Facilitate Glioma Cell Proliferation and Metastasis as a Tumorigenesis Promoter.
Ji B; Liu L; Guo Y; Ming F; Jiang J; Li F; Zhao G; Wen J; Li N
Comput Math Methods Med; 2021; 2021():5594973. PubMed ID: 33833824
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of TRIM47 inhibits glioma cell proliferation, migration and invasion through the inactivation of Wnt/β-catenin pathway.
Chen L; Li M; Li Q; Xu M; Zhong W
Mol Cell Probes; 2020 Oct; 53():101623. PubMed ID: 32603762
[TBL] [Abstract][Full Text] [Related]
9. TRIM47 activates NF-κB signaling via PKC-ε/PKD3 stabilization and contributes to endocrine therapy resistance in breast cancer.
Azuma K; Ikeda K; Suzuki T; Aogi K; Horie-Inoue K; Inoue S
Proc Natl Acad Sci U S A; 2021 Aug; 118(35):. PubMed ID: 34433666
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of high mobility group box 1 with poor prognosis in patients after radical prostatectomy.
Li T; Gui Y; Yuan T; Liao G; Bian C; Jiang Q; Huang S; Liu B; Wu D
BJU Int; 2012 Dec; 110(11 Pt C):E1125-30. PubMed ID: 22672360
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.
Zhang X; Wang Y; Ning Y
Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of SUMO-specific protease 1 (SENP1) in prostate cancer patients undergoing radical prostatectomy.
Li T; Huang S; Dong M; Gui Y; Wu D
Urol Oncol; 2013 Nov; 31(8):1539-45. PubMed ID: 23089540
[TBL] [Abstract][Full Text] [Related]
13. Anti-fibrotic effect of melittin on TRIM47 expression in human embryonic lung fibroblast through regulating TRIM47 pathway.
Li L; Zhang S; Wei L; Wang Z; Ma W; Liu F; Shen Y; Zhang S; Zhang X; Hang Y; Qian Y
Life Sci; 2020 Sep; 256():117893. PubMed ID: 32502539
[TBL] [Abstract][Full Text] [Related]
14. Efp/TRIM25 and Its Related Protein, TRIM47, in Hormone-Dependent Cancers.
Azuma K; Inoue S
Cells; 2022 Aug; 11(15):. PubMed ID: 35954308
[TBL] [Abstract][Full Text] [Related]
15. Low p27 expression predicts poor disease-free survival in patients with prostate cancer.
Yang RM; Naitoh J; Murphy M; Wang HJ; Phillipson J; deKernion JB; Loda M; Reiter RE
J Urol; 1998 Mar; 159(3):941-5. PubMed ID: 9474188
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Mel-18 expression in prostate cancer tissues and correlation with clinicopathologic features.
Wang W; Lin T; Huang J; Hu W; Xu K; Liu J
Urol Oncol; 2011; 29(3):244-51. PubMed ID: 19395284
[TBL] [Abstract][Full Text] [Related]
17. PPM1D as a novel biomarker for prostate cancer after radical prostatectomy.
Jiao L; Shen D; Liu G; Jia J; Geng J; Wang H; Sun Y
Anticancer Res; 2014 Jun; 34(6):2919-25. PubMed ID: 24922655
[TBL] [Abstract][Full Text] [Related]
18. Expression levels of heat shock protein 27 and cellular FLICE-like inhibitory protein in prostate cancer correlate with Gleason score sum and pathologic stage.
Lee SW; Cho JM; Cho HJ; Kang JY; Kim EK; Yoo TK
Korean J Urol; 2015 Jul; 56(7):505-14. PubMed ID: 26175869
[TBL] [Abstract][Full Text] [Related]
19. Prognostic implications of tissue and serum levels of microRNA-128 in human prostate cancer.
Sun X; Yang Z; Zhang Y; He J; Wang F; Su P; Han J; Song Z; Fei Y
Int J Clin Exp Pathol; 2015; 8(7):8394-401. PubMed ID: 26339409
[TBL] [Abstract][Full Text] [Related]
20. Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy.
Rosenbaum E; Hoque MO; Cohen Y; Zahurak M; Eisenberger MA; Epstein JI; Partin AW; Sidransky D
Clin Cancer Res; 2005 Dec; 11(23):8321-5. PubMed ID: 16322291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
